Metraipolis › archive › dc_e180ce2df6b7

A Case of Metastatic Melanoma Refractory to Immunotherapy: Is Cytotoxic Chemotherapy Still an Effective Option? — Europe PMC PMID:41909336

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41909336
DOI
10.7759/cureus.104178
License (as archived)
solo-consultazione
Archived
2026-11-05T09:14:46.399Z
SHA-256 of the archived text
290dd56d58b8bbabb678abc1c8a750a51a89356a6639f842089874bd71ae334a
Stable URL of this page
https://metraipolis.com/documento/dc_e180ce2df6b7

How to cite

A Case of Metastatic Melanoma Refractory to Immunotherapy: Is Cytotoxic Chemotherapy Still an Effective Option? — Europe PMC PMID:41909336 — Europe PMC (en), https://europepmc.org/article/MED/41909336 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e180ce2df6b7 (Metraipolis archive dc_e180ce2df6b7, sha256 290dd56d58b8bbabb678abc1c8a750a51a89356a6639f842089874bd71ae334a)
BibTeX
@misc{dce180ce2df6b7,
  title = {A Case of Metastatic Melanoma Refractory to Immunotherapy: Is Cytotoxic Chemotherapy Still an Effective Option? — Europe PMC PMID:41909336},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41909336},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e180ce2df6b7; sha256 290dd56d58b8bbabb678abc1c8a750a51a89356a6639f842089874bd71ae334a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41909336. Agents can read the archived copy with the MCP tool read_document.